Scarlet fever | Health topics A to Z | CKS - NICE
Scarlet fever (or 'scarlatina') is an notifiable infectious disease caused by toxin-producing strains of the bacterium Streptococcus pyogenes, also known as group A streptococcus (GAS). The incubation period is usually 2–3 days.
Scenario: Management | Management | Scarlet fever - CKS | NICE
Scarlet fever: Scenario: Management of scarlet fever Last revised in September 2024 Covers the management of suspected or confirmed scarlet fever in primary care.
Diagnosis | Scarlet fever | CKS - NICE
Be alert for clinical features of scarlet fever in people who are at increased risk of invasive Group A streptococcal (iGAS) infection and its complications. Consider an alternative diagnosis if symptoms and signs are atypical, particularly in older children and adults.
Management | Scarlet fever | CKS | NICE
Scenario: Management: Covers the management of suspected or confirmed scarlet fever in primary care.
Diagnosis | Scarlet fever | CKS | NICE
Last revised in September 2024. Diagnosis. Investigations. Differential diagnosis. The content on the NICE Clinical Knowledge Summaries site (CKS) is the copyright of Clarity Informatics Limited (trading as Agilio Software Primary Care).
Complications | Background information | Scarlet fever | CKS - NICE
Serious complications of scarlet fever are generally rare. Suppurative complications are due to local spread of the infection and tend to occur early in the course of infection : Acute sinusitis and mastoiditis — see the CKS topic on Sinusitis for more information.
Azithromycin | Prescribing information | Scarlet fever - CKS
Advise patients to report any signs or symptoms of neutropenia (fever, sore throat, swollen glands, mouth ulcers, infections). Statins — there is a possible increased risk of myopathy. Advise the person to report any muscle pain, tenderness, or weakness.
Scarlet fever: Phenoxymethylpenicillin - CKS | NICE
Adults: 500 mg four times daily, or 1000 mg twice daily (increased if necessary up to 1000 mg four times daily) for 10 days. Children aged: 1-11 months — 62.5 mg 4 times daily, or 125 mg twice daily for 10 days. 1-5 years — 125 mg 4 times daily, or 250 mg twice daily for 10 days.
Investigations | Diagnosis | Scarlet fever | CKS | NICE
These recommendations are based on the UK Health Security Agency (UKHSA) Guidelines for the public health management of scarlet fever outbreaks in schools, nurseries and other childcare settings [UKHSA, 2023a], and expert opinion in a chapter on Streptococcus pyogenes: Pharyngitis and scarlet fever in a medical textbook [Wessels, 2022].
Prescribing information | Scarlet fever | CKS | NICE
Important aspects of prescribing information relevant to primary healthcare are covered in this section specifically for the drugs recommended in this CKS topic.